P2.04-21 Real World Experience of Immune Checkpoint Inhibitors in NSCLC: Our First 10 Months Experience at Leeds Cancer Centre, UK
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1245
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV